{"code":"相关文本","name":"国家药监局关于境外已上市药品获批前商业规模批次产品进口有关事宜的公告（2025年第96号）","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"国家药监局关于境外已上市药品获批前商业规模批次产品进口有关事宜的公告（2025年第96号）"}
{"code":"相关文本","name":"国家药品监督管理局关于ω-3鱼油脂肪乳注射液说明书增加儿童用药信息的公告（2025年第85号）","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"国家药品监督管理局关于ω-3鱼油脂肪乳注射液说明书增加儿童用药信息的公告（2025年第85号）"}
{"code":"相关文本","name":"国家药监局关于发布中药生产监督管理专门规定的公告（2025年第79号）","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"国家药监局关于发布中药生产监督管理专门规定的公告（2025年第79号）"}
{"code":"相关文本","name":"国家药监局关于28批次不符合规定药品的通告（2025年第30号）","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"国家药监局关于28批次不符合规定药品的通告（2025年第30号）"}
{"code":"相关文本","name":"国家药监局关于恢复法速达制药公司氯雷他定原料药进口通关备案的公告（2025年第78号）","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"国家药监局关于恢复法速达制药公司氯雷他定原料药进口通关备案的公告（2025年第78号）"}
{"code":"相关文本","name":"国家药监局 公安部 国家卫生健康委关于发布药用类麻醉药品和精神药品目录的公告（2025年第55号）","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"国家药监局 公安部 国家卫生健康委关于发布药用类麻醉药品和精神药品目录的公告（2025年第55号）"}
{"code":"相关文本","name":"本站由国家药品监督管理局主办  版权所有：国家药品监督管理局","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"本站由国家药品监督管理局主办  版权所有：国家药品监督管理局"}
{"code":"相关文本","name":"备案序号:京ICP备13027807号","source":"https://www.nmpa.gov.cn/yaopin/ypggtg/index.html","extractedAt":"2025-10-14T11:21:01.408Z","strategy":"text","originalText":"备案序号:京ICP备13027807号"}
{"code":"相关文本","name":"国家药监局批准莫米司特片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.634Z","strategy":"text","originalText":"国家药监局批准莫米司特片上市"}
{"code":"相关文本","name":"血液制品生产智慧监管工作推进会在江西召开","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.634Z","strategy":"text","originalText":"血液制品生产智慧监管工作推进会在江西召开"}
{"code":"相关文本","name":"《中药生产监督管理专门规定》发布","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.634Z","strategy":"text","originalText":"《中药生产监督管理专门规定》发布"}
{"code":"相关文本","name":"国家药监局附条件批准宗艾替尼片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.634Z","strategy":"text","originalText":"国家药监局附条件批准宗艾替尼片上市"}
{"code":"相关文本","name":"国家药监局附条件批准泽美妥司他片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.634Z","strategy":"text","originalText":"国家药监局附条件批准泽美妥司他片上市"}
{"code":"相关文本","name":"国家药监局批准口服六价重配轮状病毒减毒活疫苗（Vero细胞）上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准口服六价重配轮状病毒减毒活疫苗（Vero细胞）上市"}
{"code":"相关文本","name":"国家药监局批准注射用德达博妥单抗上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准注射用德达博妥单抗上市"}
{"code":"相关文本","name":"国家药监局批准地罗阿克片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准地罗阿克片上市"}
{"code":"相关文本","name":"国家药监局附条件批准盐酸阿曲生坦片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局附条件批准盐酸阿曲生坦片上市"}
{"code":"相关文本","name":"国家药监局批准中药创新药参蒲颗粒上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准中药创新药参蒲颗粒上市"}
{"code":"相关文本","name":"国家药监局公布药品说明书适老化及无障碍改革试点名单（第五批）","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局公布药品说明书适老化及无障碍改革试点名单（第五批）"}
{"code":"相关文本","name":"国家药监局批准雷尼基奥仑赛注射液上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准雷尼基奥仑赛注射液上市"}
{"code":"相关文本","name":"国家药监局批准盐酸妥诺达非片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准盐酸妥诺达非片上市"}
{"code":"相关文本","name":"黄果在四川调研放射性药品研发工作","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"黄果在四川调研放射性药品研发工作"}
{"code":"相关文本","name":"国家药监局批准重组人白蛋白注射液（水稻）上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准重组人白蛋白注射液（水稻）上市"}
{"code":"相关文本","name":"国家药监局批准玛硒洛沙韦片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局批准玛硒洛沙韦片上市"}
{"code":"相关文本","name":"国家药监局附条件批准利沙托克拉片上市","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"国家药监局附条件批准利沙托克拉片上市"}
{"code":"相关文本","name":"本站由国家药品监督管理局主办  版权所有：国家药品监督管理局","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.635Z","strategy":"text","originalText":"本站由国家药品监督管理局主办  版权所有：国家药品监督管理局"}
{"code":"相关文本","name":"备案序号:京ICP备13027807号","source":"https://www.nmpa.gov.cn/yaopin/ypjgdt/index.html","extractedAt":"2025-10-14T11:21:04.636Z","strategy":"text","originalText":"备案序号:京ICP备13027807号"}
